Sara Carmen
AstraZeneca (Singapore)(SG)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, IL-33, ST2, and ILC Pathways, Eosinophilic Esophagitis, Nanofabrication and Lithography Techniques, T-cell and B-cell Immunology
Most-Cited Works
- → Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator(2003)481 cited
- → Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation(2015)262 cited
- → Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction(2023)96 cited
- → Generation of Naive Human Antibody Libraries(2001)12 cited
- → Engineering the expression of an anti-interleukin-13 antibody through rational design and mutagenesis(2017)10 cited
- → Tozorakimab (MEDI3506): a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction(2023)2 cited
- → Abstract B10: Individual CAR-T cells, when activated via their CAR or TCR, kill tumor cells with similar kinetics and can kill multiple sequential tumor targets(2015)
- → Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library(2025)